NDC 70092-611

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 70092-611
Product root: 70092-611
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	70092-611	70092-611-44	COMPOUNDER	Outsourcing facility compounded drug report	2025-2	2026-08-12
compounder	package	70092-611	70092-611-44	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	2025-09-25
compounder	package	70092-611	70092-611-44	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	2026-08-12
compounder	package	70092-611	70092-611-44	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	2025-09-25
compounder	package	70092-611	70092-611-44	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	2026-08-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Reporting period, Snapshot table
Captured / source date	Reporting period	Snapshot	Source SHA-256
2025-12-16 00:49 UTC · source 2025-09-25	2025-1	`3f6f48d8db7b…`	`6316a3eebc6a…`
2025-12-16 00:49 UTC · source 2025-09-25	2024-2	`3f6f48d8db7b…`	`6316a3eebc6a…`
2025-08-27 00:00 UTC · source 2025-08-20	2025-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	2024-2	`af8e9b524e63…`	`ca326a94a5e9…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
QuVa Pharma, Inc.	079937015	70092-611	70092-611-44	Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride	120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL	2025-2	valid
QuVa Pharma, Inc.		70092-611	70092-611-44	L.E.T. Gel 3 ml in 5 ml TS	120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL	2025-1	valid
QuVa Pharma, Inc.	079937015	70092-611	70092-611-44	Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride	120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL	2025-1	valid
QuVa Pharma, Inc.		70092-611	70092-611-44	L.E.T. Gel 3 ml in 5 ml TS	120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL	2024-2	valid
QuVa Pharma, Inc.	079937015	70092-611	70092-611-44	Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride	120 mg/3 mL; 15 mg/3 mL; 1.5 mg/3 mL	2024-2	valid